
- Volume 0 0
Statins Can Cut Risk of Sepsis
The results of a recent study showed that statins canreduce the risk of severe infection in patients suffering fromheart disease and stroke. Researchers said that the drugs cuthospital admissions for sepsis by almost 20% in patients whohad been treated previously for cardiovascular disease. Thefindings were reported in the January 25, 2006, on-line editionof the medical journal The Lancet.
The study involved 69,168 elderly patients who wereadmitted to the hospital for acute coronary syndrome,stroke, or a revascularization procedure. Upon dismissalfrom the hospital, more than 34,000 patients were prescribeda statin within 90 days, while an equal number werenot. After 2 years, 551 patients who had been taking thestatins were admitted back to the hospital for sepsis, comparedwith 667 who had not taken these drugs.
According to the researchers, "the use of statins inpatients older than 65 years old with atherosclerosis . . . wasassociated with a 19% reduced risk of sepsis." They alsocalled for more clinical trials to test the effectiveness ofstatins against sepsis. If the finding is replicated in othertrials, the researchers believe that the use of statins may beimportant in reducing the risk of sepsis in any patient undergoingcomplex surgery. In addition, patients undergoing highrisksurgery should consider taking statins to prevent sepsis.
Articles in this issue
over 19 years ago
British Poll Shows People Denying Weight Problemsover 19 years ago
Suing a Lawyer for Malpractice?over 19 years ago
Pharmacists—Cops or Not? (Part 1)over 19 years ago
Can You Read These Rxs?over 19 years ago
Alternative Measures for Treating Pediculosisover 19 years ago
Compounding Hotlineover 19 years ago
Obesity May Lead to Kidney Failureover 19 years ago
Body Fat Associated with Alzheimer's Proteinover 19 years ago
Midlife Obesity May Cause Heart Diseaseover 19 years ago
The Evolution of Imprint IdentificationNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.